Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-05-20

First therapy to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder

View source ↗

Summary

EMA announces the first therapy approved to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications